Pathological glial tau accumulations in neurodegenerative disease: Review and case report

Neurochemistry International

Volumn 39, Issue 5-6, 2001, Pages 469-479

  Berry, Robert W ^a   Quinn, Bruce ^a   Johnson, Nancy ^a   Cochran, Elizabeth J ^b   Ghoshal, Nupur ^a   Binder, Lester I ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; DEGENERATIVE DISEASE; FRONTOTEMPORAL DEMENTIA; GLIA CELL; HUMAN; IMMUNOHISTOCHEMISTRY; MICROGLIA; NERVE CELL; OLIGODENDROGLIA; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; SPECTRUM; TARGET CELL;

AGED; DEMENTIA; FEMALE; HUMANS; NEURODEGENERATIVE DISEASES; NEUROGLIA; TAU PROTEINS;

EID: 0034808141     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(01)00054-7     Document Type: Article

References (68)

1. C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease
2. Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease
3. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: Distinction between PHF-like immunoreactivity and microtubule binding
4. The distribution of tau in the mammalian central nervous system
5. A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L)
6. Cortical and subcortical argyrophilic grains characterize a disease associated with adult onset dementia
7. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders
8. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease
9. Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease
10. Glial inclusions in CNS degenerative diseases
11. Pathogenic implications of mutations in the tau gene in pallido-ponto- nigral degeneration and related neurodegenerative disorders linked to chromosome 17
12. Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly
13. Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin
14. Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation
15. Astrocytes in other neurodegenerative diseases
16. Pick's disease: A modern approach
17. Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy
18. Widespread cytoskeletal pathology characterizes corticobasal degeneration
19. Neurodegenerative disorders with extensive tau pathology: A comparative study and review
20. Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration
21. In vitro polymerization of tau protein monitored by laser light scattering: Method and application to the study of FTDP-17 mutants
22. A new molecular link between the fibrillar and granulovacuolar lesions of Alzheimer's disease
23. Tau-66: Evidence for a novel tau conformation in Alzheimer's disease
24. Corticobasal degeneration
25. Tau gene mutation in familial progressive subcortical gliosis
26. Functional interactions between the proline-rich and repeat regions of tau enhance microtubule binding and assembly
27. Abnormal phosphorylation of the microtubule-associated protein tau (τ) in Alzheimer cytoskeletal pathology
28. Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly
29. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
30. Glial tau pathology in neurodegenerative diseases: Their nature and comparison with neuronal tangles
31. Argyrophilic thread-like structure in corticobasal degeneration and supranuclear palsy
32. Thorn-shaped astrocytes: Possibly secondarily induced tau-positive glial fibrillary tangles
33. A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease
34. Evidence for tau expression in cells of monocyte lineage and its in vitro phosphorylation by v-fms kinase
35. Differential assembly of human tau isoforms in the presence of arachidonic acid
36. Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease
37. Phosphorylation affects the ability of tau protein to promote microtubule assembly
38. Functional implications for the microtubule-associated protein tau: Localization in oligodendrocytes
39. Tau pathology in a family with dementia and a P301L mutation in tau
40. Paired helical filaments in astrocytes: Electron microscopy and immunohistochemistry in a case of atypical Alzheimer's disease
41. From genotype to phenotype: A clinical pathological, and biochemical investigation of frontotemporal dementia and parkinsonism (FTDP-17) caused by the P301L tau mutation
42. Immunocytochemical characterization of glial fibrillary tangles in Alzheimer's disease brain
43. Glial tau-positive structures lack the sequence encoded by exon 3 of the tau protein gene
44. Investigation of tau-2 positive microglia-like cells in the subcortical nuclei of human neurodegenerative disorders
45. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications
46. Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments
47. Phosphorylation determines two distinct species of Tau in the central nervous system
48. Microglial reaction in Pick's disease
49. Tau is a candidate gene for chromosome 17 frontotemporal dementia
50. Corticodentatonigral degeneration with neuronal achromasia
51. Inflammation and Alzheimer's disease
52. Frontotemporal dementia and Parkinsonism linked to chromosome 17: A new group of tauopathies
53. Familial multiple system tauopathy with presenile dementia: A disease with abundant neuronal and glial tau filaments
54. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
55. Functional distinctions within the medial temporal lobe memory system: What is the evidence?
56. Progressive Supranuclear Palsy
57. Microglial cells
58. Appearance of tau-2 immunoreactivity in glial cells in human brain with cerebral infarction
59. Entorhinal cortex pathology in Alzheimer's disease
60. Neuron-glia interactions
61. Tau 2: A probe for a Ser conformation in the amino terminus of tau
62. Multiple system atrophy: A review of 203 pathologically proven cases
63. Further observations on Tau-positive glia in the brains with progressive supranuclear palsy
64. Oligodendroglial microtubular masses: An abnormality observed in some human neurodegenerative diseases
65. Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy brain tissue
66. Paired helical filaments and straight tubules in astrocytes: An electron microscopic study in dementia of the Alzheimer type